August 29, 2018 / 6:16 AM / 3 months ago

BRIEF-Withdrawal of stent won't affect Alcon spinoff - Novartis

Aug 29 (Reuters) - Novartis AG:

* SPOKESMAN SAYS WITHDRAWAL OF GLAUCOMA STENT WILL NOT AFFECT PLANS FOR ALCON SPINOFF TO SHAREHOLDERS IN 2019, WILL NOT CHANGE ALCON’S SALES TARGETS FOR FULL YEAR Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below